FDA DEVICE FACTS
syngo.CT Brain Quantification
Siemens Medical Solutions USA, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
| Subject Device Siemens syngo.CT Brain Quantification | Predicate Device Qure.Ai Technologies qER-Quant |
|---|---|
| syngo.CT Brain Quantification is a radiological post-processing application for the analysis of non-contrast head CT images. The device is intended for automatic labeling, visualization, and quantification of intracranial structures. The software is indicated for use in the analysis of: • Intracranial Hyperdensities • Midline Shift The device is intended to be used in patients aged 18 years or above. No surgical signs must be present in the images. |
.
Tables marked from the FDA document were reconstructed automatically. Check the original FDA document (links at the end of this page) for authoritative values.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。